Last edition
News about "manufacturing strategy for Berubicin to treat glio"
CNS Pharma completes manufacturing strategy for Berubicin to treat glioma brain tumors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and CNS, provided an update on the manufacturing strategy for Berubicin drug product, its lead drug candidate for the treatment of glioma brain tumors
Manufacturing Strategy For Berubicin To Treat Glio | 17/07/2020 | By Darshana | 644
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy